Intrinsiqq
U.S. Physical Therapy Inc. logo

U.S. Physical Therapy Inc. (USPH) Insider Trading

Last 12 months

Insiders bought $325k and sold $499k on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. EVP Gen'l Counsel & Secretary Richard Binstein sold $245k on Mar 6, 11% of their stake, outside a plan.

Net open-market
−$173k
3 buys · 4 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
2 / 2
executives and directors
Last open-market buy
Sep 2026
Sep 11, 2026

Get an email when USPH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 12 – Sep 11
    Peter Francis Minan
    Director · bought 6 at avg $77.23
    $474
    0.2% of stake
  • Jun 8 – 9
    Peter Francis Minan
    Director · bought 780 at avg $62.53
    $49k
    32% of stake
  • Mar 11No plan
    Graham D. Reeve
    COO · sold 662 at $78.86
    $52k
    2.2% of stake
  • Mar 6 – 9No plan
    Graham D. Reeve
    COO · sold 1,808 at avg $82.25
    $149k
    5.6% of stake
  • Mar 6No plan
    Richard Binstein
    EVP Gen'l Counsel & Secretary · sold 3,000 at $81.64
    $245k
    11% of stake
  • Nov 24, 2025No plan
    Graham D. Reeve
    COO · sold 743 at $71.01
    $53k
    3.2% of stake
  • Nov 20, 2025
    Kathleen A Gilmartin
    Director · bought 4,000 at $69.00
    $276k
    19% of stake
  • Sep 11, 2025No plan
    Nancy Ham
    Director · sold 600 at $81.71
    $49k
    23% of stake
  • Sep 5, 2025No plan
    Eric Joseph Williams
    President and COO · sold 1,000 at $85.25
    $85k
    3.8% of stake
  • Sep 4, 2025No plan
    Christopher J Reading
    Chairman of the Board and CEO · sold 2,000 at $83.53
    $167k
    1.7% of stake
  • Aug 25, 2025No plan
    Carey P Hendrickson
    Chief Financial Officer · sold 698 at $86.11
    $60k
    2.4% of stake
  • Aug 21, 2025No plan
    Graham D. Reeve
    COO · sold 763 at $84.97
    $65k
    3.2% of stake
  • Aug 11, 2025No plan
    Graham D. Reeve
    COO · sold 1,792 at $86.57
    $155k
    6.9% of stake
  • Jun 12, 2025No plan
    Nancy Ham
    Director · sold 400 at $78.01
    $31k
    13% of stake
  • May 21, 2025No plan
    Graham D. Reeve
    COO · sold 530 at $78.08
    $41k
    2.0% of stake
  • May 21, 2025No plan
    Eric Joseph Williams
    President and COO · sold 633 at $78.09
    $49k
    2.3% of stake
  • Mar 7, 2025No plan
    Graham D. Reeve
    COO · sold 1,730 at $82.11
    $142k
    6.2% of stake
  • Dec 9, 2024No plan
    Carey P Hendrickson
    Chief Financial Officer · sold 516 at $96.25
    $50k
    2.5% of stake
  • Nov 12, 2024No plan
    Bernard A Harris Jr
    Director · sold 2,000 at $92.95
    $186k
    11% of stake
  • Nov 8, 2024No plan
    Nancy Ham
    Director · sold 1,172 at $96.72
    $113k
    51% of stake
  • Nov 8, 2024No plan
    Graham D. Reeve
    COO · sold 1,724 at $96.29
    $166k
    7.9% of stake
  • Nov 8, 2024No plan
    Eric Joseph Williams
    Co-Chief Operations Officer · sold 2,000 at $95.84
    $192k
    12% of stake
  • Nov 8, 2024No plan
    Clayton Trier
    Director · sold 2,000 at $95.78
    $192k
    24% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch USPH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Health Services

Spot a number that looks wrong? Check it in USPH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing USPH

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.